cepharanthine has been researched along with dinoprostone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Gondo, H; Koga, Y; Nihashi, Y; Nomoto, K; Taniguchi, K | 1 |
Karki, R; Kim, DW; Paudel, KR | 1 |
3 other study(ies) available for cepharanthine and dinoprostone
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Thymus-dependent increase in number of T cells in parathymic lymph nodes induced by the biscoclaurine alkaloid, cepharanthine.
Topics: Alkaloids; Animals; Antigens, Surface; Benzylisoquinolines; Cell Differentiation; Cell Movement; Dinoprostone; Female; Interleukin-2; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred C3H; Mitogens; Prostaglandins E; T-Lymphocytes; Thymus Gland | 1985 |
Cepharanthine inhibits in vitro VSMC proliferation and migration and vascular inflammatory responses mediated by RAW264.7.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Becaplermin; Benzylisoquinolines; Biphenyl Compounds; Cell Movement; Cell Proliferation; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Humans; Iron; Lipid Peroxidation; Mice; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide; Nitric Oxide Synthase Type II; Picrates; Proto-Oncogene Proteins c-sis; RAW 264.7 Cells | 2016 |